1/95
Looks like no tags are added yet.
anemia
any hgb or hct value that is 2 standard dev belpw the mean for age and sex
lower limit hgb 6months-2years
11.0
lower limit hgb 2-6yo
11.0
lower limit hgb 6-12yo
11.2
whendoes snemia usually become sx
hgb 7 or 8
clinical fts of anemia
pallor, fatigue, irritability, and decreased exercise intolerance
flow murmur may be present
severe: tahcypnea, tachy, aand ulimately heart failure
acute anemia
poorly compensated- more sx
chronic anemia clinical fts
well tolerated-compensated
anemia of chronic disease→ growth failure or poor weight gain
chronic hemolytic anemiass→ expansion of bine marrow with prominent cheek bonesm frontal bossing, and dental malocclusion
splenomegaly and jaundice may be present
LAD and hepatosplenomegaly occur with infiltrative disease of bone marrow
most common cause if anemia in children
IDA
IDA RF
perinatal: prematurity or maternal iron def
cows milk- toddlers, infants
menstruating adolescent females
dietary- toddlers, ,owe SES
malabsorptieve disease- celiac
chronic GI blood loss- IBD
lead exposures
IDA clinical manifestations
CNS- irritability, poor concentration
cardiac- mumrur (systolic), elav HR
fatigue, pallor, poor exercise tolerance, HA, syncope
IDA screenign
complete CBC and serum ferritn
universal screengin perf once for all infants
breastfed priamrily- btwn 9-12minths
iron fortified formula primarily- btwn 15-18months
IDA workup
thorough history
CBC, iron studies with ferritin
reticulocyte count, peripheral blood smear, and stool for occult blood
IDA dx- miccrocytic anemia
CBC with low hgb, low MCV, and elevated RDW
IDA dx-normocytic anemia
CBC with low hgb, nomral MCV, elevated RDW, PLUS clinical risk factors fro IDA
IDA dx-low serum ferritin
ferritin ≤20 ng/ml in infants >9months and prepubertal children or ≤30ng/ml in adolescents (≥11yo)
IDA tx
therapeutic trial if oral iron
3mg/kg/day of ferrous sulfate
recheck CBC within 4weeks0L if no improvement, check compliance and obtain full workup and consider referral to heme
if improved-< cont and recheck in 3 moths
cont 1-2months after hgb back to normal
AND dietary changes
adequate Fe intake and avoid excess milk intake
IDA prevention
Fe supp, delayed cord clamping
preterm infants (<37weeks): start iron fortificaiton or supp by 2 weeks of life once on full enteral feeds, targeting 2-3mg/kg/day
excluseively breastfed term infants,: 1mg/kg/day by 4month
when to consider thalassemia
anemia is not responding to Fe supp
thalassemia workup
general workup for anemai
AND hgb electrophoresis to confirm
refer tto genetics and hematology
hereditary spherocytosis
MC inherited hemolytic anemia in the US
mostly autosomal dom
hereditary spherocytosis workup
CBC and reticulocyte count
variable anemai with MCHC
spherocytes oin blood smear
positive osmotic fragility test
coombs neg
genetic studies to confirm
refer to genetic ans heme
sickle cell anemia
autosomal recessive inherited disorder
sickle point mutation in beta globin gene → prod of sickle hgb
less soluble= more stiff RBCs
sickle cell occurs whn Hgb S is present in homozygous state→ Hgb SS
sickle cell anemia- clinical manifestations chronic hemolytic anemia
jaundice, pallor, variable splenomegaly in infancy
fatigue
cardiac flow murmur
delayed growth and sexual maturation
sickle cell anemia- clinical manifestations vaso occlusive crisis
acute pain episodes die to miucrovascular obstruction and tissue ischemia
dactylitis (hand-foot swelling in infancy)
can cause stroke, acute chest syndrome, and organ damage
sickle cell anemia- clinical manifestations other ocmplicaitons
functional asplenia→ increased risk of serious infecitons
renal diseases, retinopathy, gallstones, and priapism
chronic lung disease and pulm HTN
SCA- sickling triggers
hypoxia
acidosis
fever
hypothermia
dehydraiton
SCA dx
routine newborn screen
confirmation by Hgb electrophoresis
sx pts
Hgb elecreophoresis of high performance liquid chromatography
screening of relatives
SCA- referral
peds heme
oph→ starting at age 10
genetics→ new dx adn reproductive coounseling
SCA mgmt
hematology
hydroxyurea= mainstay of tx
reduces pain and vaso-occlusive crisus
transfusions
infection prevention
routine abx px until age 5
nutrition- chronic hemolytic anemai, folic acid, multivitaminiwthout iron
transcrnaial US- yearly from age 2-16
pain mgmt- opiates
potenitallu curative: boen _ blood stem cell transplant and gene therapy
life expectantcy→ shortened by about 20-30yes
sickle cell trait
heterozygous for sickle gene
Hgb HS
sickle cell trait clinical presentation
typically asx
very specific conditions→ capable of sickling
high altitude
exertional rhabdo
sickle cell trait dx
newborn screening
hgb electrophoresis
sickle cell trait referral
genetics for preconception counseling
normal life expectancy
in general, no exerices restricitons
lead poisoning
routine screengin at 12 ans 24 months
lead poisoning RF
exposure to lead based paint, artists, paintm home glazed pottery, unlletsm sibling with lead poisoning
what type of lead exposure is more concerning
repetitive small ingestions much worse than one large exposure
lead poisoning clinical presentaiton
vague sx→ weakness, irritability, weight loss, vomiting personality changes, ataxia, constipatiion, HA, and cplicky abd pain
late→ cog impairement, convulsions coma with elevated ICP
lead poisoning workup
lead level
if elevated ≥3.5 and asx-repeat to verify no lab error
CBC with diff and ferritin
Fe def increases absorption of lead
possibel basophilic stippling
abd film→ sx children or those with hx of pica or acut eingestion of lead containign objects
lead poisoning dx
elevated blood lead level
lead poisoning tx
≥3.5= actionable level
<45mcg/dL= NO chelation
notify public health
screen other children in home
follow up screening with schedule dertmined by the original level
≥45= chelation therapy
refer to peds environmental health specialty unit or regional posion conteol
hospitalize if >69
lead poisoning prevention
screen!!
primary prevention os the only way to reduce neurocog effects
remove hazards from home
most common cancers in children and adolescents
1) leukemia
2) CNS tumors
3) lyumphoma
cancers almost exclusive to children
neuroblastoma
wilms tumor
retinoblastoma
hepatoblastoma
s/sx of childhood cancer are nonspecific
pain
fatigue
pallor, brusing,/petichiae/bleeding
growing mass
leukemia- ALL
acute lymphoblastic leukemia
75% of keukemia cases→ MOST COMMON childhood cancer
B cell or T cell
peaks at age 2-4
M>F
can also have Phili chromosome in some subtypes
leukemia- CML
chronic myeloid leukemia
translocation involving chormosomes ( and 22 (phili chrom)
leukemia- AML
acute myeloid leukemia
20%
neonatal period and adolescnece
leukemia RF
T21
NF1
siblign with leukemia
radiation, chemical exposure
leukemia- clinical presesntation
common presenting:
fever, pallor, petichiae and or ecchymoiss, lethargy, malaise, anorexia, and boen.joint pain
boen marrow failure- anemia, neutropenia, thrimbocytopenai
specific tissue infiltratio- lymph nodes, liver, spleen, brain, bone, skin, gongiva, testes
on exam:
LAD adn hepatosplenomegaly, neuro sx or painless testiculat enlargement
leukemia workup
CBC with smear
anemia, thrombocytopenia
immature blasts
boen marroe aspirate/bx
immature blasts
CXR
possibel mass
CMP
electrolytes, renal, and hepatic fucntion
urinc acud
leukemia dx
immature blasts on peripheral smear, bone marrow aspirate or both
definitive dx requires eval of cell surface markers by flow cytometry
cytogenic studies
leukemia tx
ALL- chemo
AML- chemo, rad, possibel stem cell transplant
CML- tyrosine kinas einhib (TKIs), possibel chemo
lymphoma
cancer of lymphoid tissue
hodgkin lymphoma
non hodgkin lymphoma
peaks in adolescents/yougn adult and again after age 50
lymphoma eti
multifactorial
associated with EBV
lymphoma clinical pres
most often→ PAINLESS, frim LAD
supraclavicualr and cervical nodes
medistinal LAD→ sough, SHOB
B cell type of NHL→ feverm night sweats and weight loss
lymphoma workup
CBC
ESR
CMP
lactate dehydrogenase
uric acid
CXR
lymphoma dx
tissue or fluid sample
bx
hodgkin= reeds sternberg cells
PET, LP, an d boen marrow bx for staging
HL tx
possibel surgery, chemo/rad
NHL tx
less localized
chemo
possibel surgery, rad, boen marroe transplant
metastases are common
lymphoma prognosis
HL- highly durable
HL- >60% survivial
central nervous system tumors
most CNS tumors in children are primary tumors
adults→ metastesis
leadign cause of childhood cancer deaths
peaks before age 10 then decreases until second peak after age 70
types of central nervous sytem tumors
cerebellar astrocystomas
medulloblastoma
glioblastoma multiforme
optic nerve glioma
CNS tumoe clinical presentaiton
impingement on normal tissue
irritabilitym anorexia, poor school performance, and loss of dev milestones
increase in ICP
HA, vom (in AM), and lethargy
can also hae increase in head circumferance, loss of VA or visual field deficits, seizure, ataxia, precocious or diabetes insip
CNS tumor- workup
MRI- imaging of chocie
LP→ AFTER MRI
CNS tumor tx
dpends on type of tumor, sizem locationm and associated sx
dexamethasone
surgery
± chemo or rad
neuroblastoma
mcost common malignancy in infants
derived from neural crest cells that form the adrenal medulla and sympathetic nervous system
cause= unknonw
rarely hereditary
median age at dx→ 17months
neuroblastoma clinical presentation
if loaclized→ asx
if mets→ syste,mic illness, fever, weight loss, and pain
nontender mass in abd, flank, or neck
can met to skin, liver, bone marrow,a and lymph nodes
if spreads to bones of orbit→ bruising around eyes
neuroblastoma workup
CBC
abd xray
calcificaitions
urine catecholamines
tumor markers: urine homovanillic acid (HVA) and vanillymandekic acis (VMA)
CT of shest, abd, and pelvis
boen scan
bone marrow aspiration/bx
neuroblastoma dx
tissue bx
genetic testing
neuroblastoma tx
base don risk classificaiton
suegery
± chemo or rad
neuroblastoma prognosis
depends on age, stagem histology
more avorable is young and localized
poor if older and metastatic
retinoblastoma
malignancy of the retina and most common intraocular tumor in children
peaks durign first 2 years of life
sporadic retinoblastoma
60%
U/L
presents at a later age
inherited retinoblastoma
mutation in gene
500 fold increaseed risk of osteoscarcoma for individuals with hereditary retinoblastoma
B/L
presents at an earlier age
retinoblastoma clinical presentation
leukocoria
strabismus, nystagmus, and red eye
if not treated→ globe destroyed and mets→ death
retinoblastoma workup
oph
ocular US, optical coherence tomography
MRI of brain and orbits
Rb gene analysis
if mets→ LP, boen marroe aspiration and bx, bone scan
retinoblastoma dx
dilated eye exam
imaging
retinoblastoma tx
intraocular chemo
systemic chemo
retinoblastoma prognosis
vision depends on extent of tumor
risk of malignancy- most commonlu osteosarcoma
wilm tumor (nephroblastoma)
cause is unknown
can be hereditary
most common malignant renal tumor of childhood
U/L tumor- median age of dx at 44 moths
B/L tumors (more common with hereditary form)- dx at 31 months
wilm tumor (nephroblastoma) clinical presentation
abd mass
abd pain, fever, HTN, and hematuria
wilm tumor (nephroblastoma) workup
abd US or CT
CBC
UA
liver and renal fucntion
tp look fro mets→ CT of chest, abd, and pelvis
wilm tumor (nephroblastoma) dx
bx
wilm tumor (nephroblastoma) tx
nephrecotmy (can be curatie)
chemo ± rad
hepatoblastoma
primary liver tumor
usually present before age 5
eti unknonw
increased risk with prematurity
hepatoblastoma clinical presentaiton
abd mass
abd pain, n/v
hepatoblastoma wotkup
CT or MRI
tumor marker- serum alpha fetoproein (APP)
LFTs- noemal or slightly elevated
hepatoblastoma tx
resection or transplant
chemo
sarcomas
soft tissue cancers
from connective tissues
rhabdomyosarcoma, fibrosarcoma, synovial sarcoma and extraosseus eqig sarcoma
peaks in children 2-6yo
boen cancers
ewign sarcoma→ peaks at age 10 and 20 years
osteosarcoma→ adolescents
sarcomas eti
unnknonw
increased ris kin NF1, retinoblastoma (hereditary), prior rad or chemo
sarcomas clinical presentaiton
depends on site, mass, effect and mets
fatigue, feverm adn WL
orbital tumor→ periorbital swelling, proptosis, and limited EOMs
osteosarcoma→ epephysis or metaphysis of logn bones- pain and assoicated palpable mass
ewing sarcoma→ femur and pelvis
sarcomas workup
XRAY- lytic lesion
mets/staging- MRI, chest CT adn boen scan
sarcomas tx
based on stage
surgical reection, chemo, ± rad
sarcomas prognosis
depends in if metastatic adn disease present
poor prog for distant mets- 20% survival
excellent if localized
findings to never ignore
s/sx of increased ICP
leukocoria
abd mass
painless, firm, fixed, nontender masses
abnomral brusing/bleeding
persistent boen pain
weight loss